Nautilus Biotechnology Inc (NAUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 18,060 | 16,304 | 15,820 | 15,472 | 16,022 |
| Operating Income | -18,060 | -16,304 | -15,820 | -15,472 | -16,022 |
| Other Income | 3,095 | 2,895 | 1,757 | 783 | 259 |
| Pre-tax Income | -14,965 | -13,409 | -14,063 | -14,689 | -15,763 |
| Net Income Continuous | -14,965 | -13,409 | -14,063 | -14,689 | -15,763 |
| Net Income | $-14,965 | $-13,409 | $-14,063 | $-14,689 | $-15,763 |
| EPS Basic Total Ops | -0.12 | -0.10 | -0.11 | -0.12 | -0.13 |
| EPS Basic Continuous Ops | -0.12 | -0.11 | -0.11 | -0.12 | -0.13 |
| EPS Diluted Total Ops | -0.12 | -0.10 | -0.11 | -0.12 | -0.13 |
| EPS Diluted Continuous Ops | -0.12 | -0.11 | -0.11 | -0.12 | -0.13 |
| EBITDA(a) | $-17,558 | $-15,933 | $-15,153 | $-14,816 | $-15,190 |